Literature DB >> 4214781

Purification and some properties of progenitor toxins of Clostridium botulinum type B.

S Kozaki, S Sakaguchi, G Sakaguchi.   

Abstract

Purification of progenitor toxin of Clostridium botulinum type B strain Okra was undertaken by sequential steps of acid precipitation, extraction, ammonium sulfate precipitation, ribonuclease digestion, acid precipitation, protamine treatment, sulphopropyl-Sephadex chromatography, and Sephadex G-200 gel filtration. Two different molecular-sized toxins, named large (L) and medium (M) toxins, were obtained. L toxin was centrifugally homogeneous but electrophoretically heterogeneous. It contained 2.5 x 10(8) to 3.0 x 10(8) mean lethal doses per mg of nitrogen, and its sedimentation constant was 16S. M toxin was centrifugally and electrophoretically homogeneous. It contained 5.5 x 10(8) to 6.0 x 10(8) mean lethal doses per mg of nitrogen, and its sedimentation constant was 12S. The presence of both L and M toxins in spent culture was demonstrated. It seems justified, therefore, to call both progenitor toxins. Both consisted of toxic and nontoxic components. The toxic components of L and M toxins appeared to be identical with each other. The nontoxic component of L toxin was 12S and possessed a hemagglutinin activity of about 0.5% that of type A crystalline toxin; that of M toxin was 7S and possessed no hemagglutinin activity. They were antigenically related but not identical.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214781      PMCID: PMC423017          DOI: 10.1128/iai.10.4.750-756.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.

Authors:  G Sakaguchi; S Sakaguchi; S Kozaki; S Sugii; I Oishi
Journal:  Jpn J Med Sci Biol       Date:  1974-06

2.  Isolation of chromatographically pure toxin of Clostridium botulinum type B.

Authors:  B R DasGupta; D A Boroff; K Cheong
Journal:  Biochem Biophys Res Commun       Date:  1968-09-30       Impact factor: 3.575

3.  Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration.

Authors:  B R DasGupta; D A Boroff
Journal:  J Biol Chem       Date:  1968-03-10       Impact factor: 5.157

4.  Significance of 12S toxin of Clostridium botulinum type E.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

5.  Purification and some properties of Clostridium botulinum type-E toxin.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1968-10-21

6.  Botulinal toxins and the problem of nomenclature of simple toxins.

Authors:  C Lamanna; G Sakaguchi
Journal:  Bacteriol Rev       Date:  1971-09

7.  Isolation and characterization of Clostridium botulinum type B toxin.

Authors:  W H Beers; E Reich
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice.

Authors:  G Sakaguchi; S Sakaguchi; H Kondo
Journal:  Jpn J Med Sci Biol       Date:  1968-12

9.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

10.  Purification and characterization of Clostridium botulinum type B oxin.

Authors:  J Gerwing; C E Dolman; D V Kason; J H Tremaine
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

View more
  31 in total

1.  Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.

Authors:  Hideyuki Arimitsu; Kaoru Inoue; Yoshihiko Sakaguchi; Jaechul Lee; Yukako Fujinaga; Toshihiro Watanabe; Tohru Ohyama; Robert Hirst; Keiji Oguma
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Molecular construction of Clostridium botulinum type F progenitor toxin.

Authors:  I Ohishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1975-04

4.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

5.  Observations on toxin and hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Oguma; A Nakane; H Iida
Journal:  Appl Environ Microbiol       Date:  1978-02       Impact factor: 4.792

6.  Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

Authors:  S Kozaki; J Ogasawara; Y Shimote; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.

Authors:  B Vijayalakshmi Ayyar; K Roger Aoki; M Zouhair Atassi
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

8.  Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.

Authors:  M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.